Citadel Advisors’s Xtant Medical Holdings XTNT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $49.3K | Sell |
66,708
-27,407
| -29% | -$20.3K | ﹤0.01% | 5460 |
|
2025
Q1 | $44.2K | Buy |
+94,115
| New | +$44.2K | ﹤0.01% | 5398 |
|
2024
Q4 | – | Sell |
-79,356
| Closed | -$53.6K | – | 6880 |
|
2024
Q3 | $53.6K | Buy |
79,356
+3,909
| +5% | +$2.64K | ﹤0.01% | 5093 |
|
2024
Q2 | $47.5K | Buy |
75,447
+9,994
| +15% | +$6.3K | ﹤0.01% | 5192 |
|
2024
Q1 | $76.6K | Buy |
65,453
+5,587
| +9% | +$6.54K | ﹤0.01% | 5182 |
|
2023
Q4 | $67.6K | Buy |
59,866
+28,105
| +88% | +$31.8K | ﹤0.01% | 5007 |
|
2023
Q3 | $34.9K | Buy |
31,761
+4,652
| +17% | +$5.12K | ﹤0.01% | 5197 |
|
2023
Q2 | $25.2K | Buy |
27,109
+4,606
| +20% | +$4.28K | ﹤0.01% | 5200 |
|
2023
Q1 | $14.3K | Sell |
22,503
-21,155
| -48% | -$13.5K | ﹤0.01% | 5459 |
|
2022
Q4 | $28.8K | Buy |
+43,658
| New | +$28.8K | ﹤0.01% | 5456 |
|
2021
Q3 | – | Sell |
-36,531
| Closed | -$60K | – | 7200 |
|
2021
Q2 | $60K | Sell |
36,531
-55,442
| -60% | -$91.1K | ﹤0.01% | 6153 |
|
2021
Q1 | $217K | Buy |
91,973
+24,917
| +37% | +$58.8K | ﹤0.01% | 5341 |
|
2020
Q4 | $80K | Buy |
+67,056
| New | +$80K | ﹤0.01% | 4747 |
|
2018
Q1 | – | Sell |
-1,138
| Closed | -$8K | – | 4472 |
|
2017
Q4 | $8K | Buy |
+1,138
| New | +$8K | ﹤0.01% | 3818 |
|
2017
Q1 | – | Sell |
-3,913
| Closed | -$26K | – | 4242 |
|
2016
Q4 | $26K | Buy |
3,913
+2,390
| +157% | +$15.9K | ﹤0.01% | 3410 |
|
2016
Q3 | $21K | Buy |
+1,523
| New | +$21K | ﹤0.01% | 3411 |
|
2014
Q2 | – | Sell |
-420
| Closed | -$42K | – | 3776 |
|
2014
Q1 | $42K | Buy |
420
+266
| +173% | +$26.6K | ﹤0.01% | 3324 |
|
2013
Q4 | $9K | Buy |
+154
| New | +$9K | ﹤0.01% | 3013 |
|